What laboratory investigations are indicated for a patient with stage 4 chronic kidney disease? | Rounds What laboratory investigations are indicated for a patient with stage 4 chronic kidney disease? | Rounds
Loading...

What laboratory investigations are indicated for a patient with stage 4 chronic kidney disease?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Laboratory Investigations for Stage 4 Chronic Kidney Disease

Stage 4 chronic kidney disease (CKD G4) requires laboratory assessment of kidney function, albuminuria, electrolyte and acid-base status, complications of CKD–mineral and bone disorder, and anemia. (kdigo.org)

Kidney Function and Electrolyte/Acid-Base Status

  • Serum creatinine with estimated glomerular filtration rate (eGFR) is assessed for CKD staging and monitoring. [1]
  • Serum potassium is assessed for risk of electrolyte complications in CKD. [1]
  • Serum bicarbonate is assessed to evaluate and monitor metabolic acidosis in CKD. [1]

Albuminuria/Proteinuria Assessment

  • Albuminuria is assessed in adults and is paired with GFR to determine prognosis and monitoring intensity. [1]
  • A urine albumin-to-creatinine ratio (ACR) is used for albuminuria assessment, using an untimed urine specimen. [1]
  • When albuminuria is detected with less accurate methods, more accurate methods are recommended. [1]
  • For measuring urine protein, urine protein-to-creatinine ratio (PCR), reagent strip urinalysis for total protein, or ACR-based automated reagent strip testing is recommended depending on the measurement pathway used. [1]

CKD–Mineral and Bone Disorder Laboratory Monitoring

  • Serum calcium is monitored beginning in CKD G3a. [2]
  • Serum phosphate is monitored beginning in CKD G3a. [2]
  • Parathyroid hormone (PTH) is monitored beginning in CKD G3a. [2]
  • Alkaline phosphatase (ALP) activity is monitored beginning in CKD G3a. [2]

Anemia Screening and Evaluation

  • Anemia is screened at referral and again during follow-up in CKD. [3]
  • Diagnostic tests for anemia include complete blood count (CBC), reticulocyte count, ferritin, and transferrin saturation (TSAT). [3]
  • Stage 4 CKD is screened for anemia at least twice per year. [4]

Common Minimum Laboratory Panel in Stage 4 CKD

  • Serum creatinine with eGFR. [1]
  • Serum potassium and serum bicarbonate. [1]
  • Urine ACR (or an equivalent albuminuria/proteinuria measure used in the local diagnostic pathway). [1]
  • Serum calcium, phosphate, PTH, and ALP. [2]
  • CBC plus reticulocyte count, ferritin, and TSAT for anemia evaluation. [3]

Practical Frequency Notes for Stage 4 CKD

  • Albuminuria and GFR are assessed at least annually, with more frequent assessment when measurement results will affect therapeutic decisions. [1]
  • Serum bicarbonate is monitored to guide metabolic acidosis management and to avoid adverse effects on blood pressure control, serum potassium, and fluid status. [1]
  • Anemia testing frequency is at least twice yearly in stage 4 CKD. [4]

Targets for Interpretation of Laboratory Abnormalities

  • No single universal CKD G4 laboratory target set applies across all patients. Target interpretation is individualized to CKD complication status, including CKD–mineral and bone disorder and anemia phenotype, after baseline diagnostic evaluation. [2][3]

Related Questions